Wearable Devices Ltd. SEC Filings

Wearable Devices Ltd. Chief Financial Officer Mualem Alon filed an initial Form 3 reporting his existing equity position. He directly holds 52,083 Ordinary Shares and has stock options covering 417 shares at an exercise price of $0.7200 expiring on January 23, 2032 and 83 shares at $316.8000 expiring on November 30, 2033. Footnotes also describe RSU awards for 5,000 Ordinary Shares vesting monthly through September 10, 2026 and 37,778 Ordinary Shares vesting monthly through January 1, 2029, each RSU representing one Ordinary Share.

Wearable Devices Ltd. Chief Operating Officer Tamar Fleisher filed an initial ownership report showing direct holdings in the company’s ordinary shares and equity awards. The filing lists 23,667 Ordinary Shares, which include RSUs for 2,500 shares vesting in monthly installments of 417 shares through September 10, 2026 and RSUs for 16,056 shares vesting in monthly installments of 472 shares through January 1, 2029. Fleisher also holds stock options over 125 ordinary shares at an exercise price of 158.4000, expiring on December 15, 2032, and options over 63 ordinary shares at an exercise price of 316.8000, expiring on November 30, 2033. These entries reflect existing positions rather than new market purchases or sales.

Wearable Devices Ltd. files a post-effective amendment registering up to 2,904,500 Ordinary Shares for resale by a selling shareholder; these shares are issuable upon exercise of warrants previously issued in private placements.

The prospectus states the Company will not receive proceeds from resale by the selling shareholder, but could receive up to $18.6 million if the warrants are exercised for cash (assuming full exercise). The filing reports 3,597,740 Ordinary Shares outstanding prior to the offering and a pro forma total of 6,502,240 Ordinary Shares if all registered warrants are exercised for cash.

Wearable Devices Ltd. files its annual Form 20-F, describing a neural wristband interface business now shifting from R&D to commercialization, including its Mudra Band for Apple devices. The company reports 2,882,802 ordinary shares outstanding as of December 31, 2025 and an accumulated deficit of approximately $37.2 million.

Management discloses prior going concern doubts and expects substantial ongoing losses, emphasizing reliance on product sales and additional capital raises, including past dependence on Armistice Capital. The filing highlights intense competition from large technology companies, long B2B licensing cycles without signed licenses to date, multiple recent reverse share splits to maintain Nasdaq listing, and extensive operational, data privacy, cybersecurity and AI-related risks.

Wearable Devices Ltd. reported full-year 2025 results showing early revenue growth but continued losses. Revenue rose to $647 thousand from $522 thousand, helped by a 28.5% increase in sales of its Mudra Link and Mudra Band gesture-control products.

The company remained unprofitable, with an operating loss of $8.3 million and a net loss of $8.1 million. During 2025 it raised approximately $24.4 million in gross proceeds from equity offerings, ending the year with a cash balance of $6.5 million and short-term deposits of $11.9 million, for total current assets of $19.5 million. Total liabilities fell to $1.4 million after repaying a convertible note, and shareholders’ equity increased to $18.6 million.

Wearable Devices Ltd. is carrying out a 1‑for‑3 reverse share split of its ordinary shares and publicly traded warrants. Every three existing shares or warrants will be consolidated into one, with warrant exercise prices adjusted proportionally.

The move aims to increase the share price to help regain compliance with Nasdaq’s $1.00 minimum bid requirement and protect the company’s continued listing on the Nasdaq Capital Market. After the split, issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, and publicly held warrants from 98,589 to approximately 32,863, while authorized capital remains at 500,000,000 shares.

The split, approved by shareholders and the board at a 1‑for‑3 ratio, will take effect for trading on a split‑adjusted basis when the market opens on March 11, 2026. Fractional positions will be rounded to the nearest whole share or warrant, and outstanding equity awards and plan reserves will be adjusted proportionally.

Wearable Devices Ltd. reported that its Board of Directors approved an increase in the number of ordinary shares reserved for its 2024 Global Equity Incentive Plan. The reserve rose by 1,431,713 shares, from 2,473,856 to 3,905,569 ordinary shares.

This change expands the pool of shares available for future equity-based awards to employees, directors, and other eligible participants under the plan. The report is also incorporated by reference into the company’s existing Form S-8 and Form F-3 registration statements.

Wearable Devices Ltd. registers for the resale by a selling shareholder of up to 7,043,500 Ordinary Shares, consisting of 1,230,000 shares issuable upon exercise of October Warrants and 5,813,500 shares issuable upon exercise of November Warrants, pursuant to a Form F-1 prospectus dated February 23, 2026.

The company will not receive proceeds from shares sold by the selling shareholder; the company would receive up to $3.3 million from the October Warrants and up to $10.8 million from the November Warrants if exercised for cash. Shares outstanding were 10,211,839 as of February 20, 2026, and would be 17,255,339 assuming full cash exercise of the Warrants.